Collegium Pharmaceutical, Inc. (NASDAQ:COLL) is reporting first quarter earnings results on Wednesday 9th May 2018, after the bell.
The consensus estimates from Thomson Reuters are loss of $ 0.49 per share from $ 59.75 million in revenue.
The same period from last year, COLL reportedly had loss of $ 0.79 per share on $ 2.17 million in revenue.
For the full year, analysts predict revenues of $ 301.83 million, while looking forward to loss of $ 0.58 per share.
About Collegium Pharmaceutical, Inc.
|% Change from 52 Week Low|
|% Change from 52 Week High|